• Je něco špatně v tomto záznamu ?

The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model

D. Miklankova, I. Markova, M. Hüttl, B. Stankova, H. Malinska

. 2022 ; 2022 (-) : 4587907. [pub] 20220913

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024422

Introduction: Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results: Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions: Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024422
003      
CZ-PrNML
005      
20221031100259.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2022/4587907 $2 doi
035    __
$a (PubMed)36147256
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Miklankova, Denisa $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000287719338
245    14
$a The Different Insulin-Sensitising and Anti-Inflammatory Effects of Palmitoleic Acid and Oleic Acid in a Prediabetes Model / $c D. Miklankova, I. Markova, M. Hüttl, B. Stankova, H. Malinska
520    9_
$a Introduction: Monounsaturated fatty acids (MUFA) are understood to have therapeutic and preventive effects on chronic complications associated with type 2 diabetes mellitus (T2DM); however, there are differences between individual MUFAs. Although the effects of palmitoleic acid (POA) are still debated, POA can regulate glucose homeostasis, lipid metabolism, and cytokine production, thus improving metabolic disorders. In this study, we investigated and compared the metabolic effects of POA and oleic acid (OA) supplementation on glucose and lipid metabolism, insulin sensitivity, and inflammation in a prediabetic model, the hereditary hypertriglyceridemic rat (HHTg). HHTg rats exhibiting genetically determined hypertriglyceridemia, insulin resistance, and impaired glucose tolerance were fed a standard diet. POA and OA were each administered intragastrically at a dose of 100 mg/kg b.wt. for four weeks. Results: Supplementation with both MUFAs significantly elevated insulin and glucagon levels, but only POA decreased nonfasting glucose. POA-treated rats showed elevated circulating NEFA associated with increased lipolysis, lipoprotein lipase gene expression, and fatty acid reesterification in visceral adipose tissue (VAT). The mechanism of improved insulin sensitivity of peripheral tissues (measured as insulin-stimulated lipogenesis and glycogenesis) in POA-treated HHTg rats could contribute increased circulating adiponectin and omentin levels together with elevated FADS1 gene expression in VAT. POA-supplemented rats exhibited markedly decreased proinflammatory cytokine production by VAT, which can alleviate chronic inflammation. OA-supplemented rats exhibited decreased arachidonic acid (AA) profiles and decreased proinflammatory AA-derived metabolites (20-HETE) in membrane phospholipids of peripheral tissues. Slightly increased FADS1 gene expression after OA along with increased adiponectin production by VAT was reflected in slightly ameliorated adipose tissue insulin sensitivity (increased insulin-stimulated lipogenesis). Conclusions: Our results show that POA served as a lipokine, ameliorating insulin sensitivity in peripheral tissue and markedly modulating the metabolic activity of VAT including cytokine secretion. OA had a beneficial effect on lipid metabolism and improved inflammation by modulating AA metabolism.
650    _2
$a adiponektin $7 D052242
650    _2
$a zvířata $7 D000818
650    _2
$a antiflogistika $7 D000893
650    _2
$a kyseliny arachidonové $7 D001095
650    _2
$a cytokiny $7 D016207
650    12
$a diabetes mellitus 2. typu $7 D003924
650    _2
$a mastné kyseliny $x metabolismus $7 D005227
650    _2
$a kyseliny mastné mononenasycené $x farmakologie $x terapeutické užití $7 D005229
650    _2
$a kyseliny mastné neesterifikované $7 D005230
650    _2
$a glukagon $7 D005934
650    _2
$a glukosa $x metabolismus $7 D005947
650    _2
$a zánět $7 D007249
650    _2
$a inzulin $x metabolismus $7 D007328
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a lipoproteinlipasa $7 D008071
650    _2
$a kyselina olejová $x farmakologie $7 D019301
650    12
$a prediabetes $x farmakoterapie $7 D011236
650    _2
$a krysa rodu Rattus $7 D051381
655    _2
$a časopisecké články $7 D016428
700    1_
$a Markova, Irena $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000243317636
700    1_
$a Hüttl, Martina $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000224843630
700    1_
$a Stankova, Barbora $u First Faculty of Medicine, Charles University, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000261844878
700    1_
$a Malinska, Hana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic $1 https://orcid.org/https://orcid.org/0000000290763399
773    0_
$w MED00181720 $t Journal of diabetes research $x 2314-6753 $g Roč. 2022, č. - (2022), s. 4587907
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36147256 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100257 $b ABA008
999    __
$a ok $b bmc $g 1854247 $s 1175712
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 2022 $c - $d 4587907 $e 20220913 $i 2314-6753 $m Journal of diabetes research $n J Diabetes Res $x MED00181720
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...